Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination-Reference-Cited by-同舟云学术

Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination

Published:2014 Issue:2 Volume:78 Page:436-442
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Chida Ayako¹²,Sato Hiroki³,Shintani Masaki²,Nakayama Tomotaka⁴,Kawamura Yoichi¹,Furutani Yoshiyuki²,Inai Kei²,Saji Tsutomu⁴,Matsuoka Rumiko⁵⁶⁷,Nonoyama Shigeaki¹,Nakanishi Toshio²

Affiliation:

1. Departments of Pediatrics, National Defense Medical College

2. Department of Pediatric Cardiology, Tokyo Women’s Medical University

3. Preventive Medicine and Public Health, National Defense Medical College

4. Department of Pediatrics, Toho University Medical Center, Omori Hospital

5. International Research and Educational Institute for Integrated Medical Sciences (IREIIMS), Tokyo Women’s Medical University

6. International Center for Molecular, Cellular and Immunological Research (IMCIR), Tokyo Women’s Medical University

7. Department of Pediatrics, Faculty of Medicine, Toho University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/2/78_CJ-13-1033/_pdf

Reference28 articles.

1. 1. Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM. Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatr Res 2008; 63: 321–327.

2. 2. Bernus A, Wagner BD, Accurso F, Doran A, Kaess H, Ivy DD. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest 2009; 135: 745–751.

3. 3. Lammers AE, Hislop AA, Haworth SG. Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension. Int J Cardiol 2009; 135: 21–26.

4. 4. Takatsuki S, Wagner BD, Ivy DD. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. Congenit Heart Dis 2012; 7: 259–267.

5. 5. Schumann C, Lepper PM, Frank H, Schneiderbauer R, Wibmer T, Kropf C, et al. Circulating biomarkers of tissue remodelling in pulmonary hypertension. Biomarkers 2010; 15: 523–532.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between Soluble ST2 Level and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Acute Pulmonary Embolism (PE) Patients;Cureus;2023-07-25

2. Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases;Cytokine & Growth Factor Reviews;2023-06

3. The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension;Rheumatology;2022-01-30

4. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension;Journal of the American Heart Association;2021-10-19

5. Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in chronic thromboembolic pulmonary hypertension patients after balloon pulmonary angioplasty therapy – a cardiac magnetic resonance imaging cohort study;Pulmonary Circulation;2021-10